GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Bio-heart Biological Technology Co Ltd (HKSE:02185) » Definitions » EV-to-FCF

Shanghai Bio-heart Biological Technology Co (HKSE:02185) EV-to-FCF : -1.58 (As of Apr. 09, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Shanghai Bio-heart Biological Technology Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Shanghai Bio-heart Biological Technology Co's Enterprise Value is HK$196.96 Mil. Shanghai Bio-heart Biological Technology Co's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-124.28 Mil. Therefore, Shanghai Bio-heart Biological Technology Co's EV-to-FCF for today is -1.58.

The historical rank and industry rank for Shanghai Bio-heart Biological Technology Co's EV-to-FCF or its related term are showing as below:

HKSE:02185' s EV-to-FCF Range Over the Past 10 Years
Min: -3.15   Med: 0   Max: 0
Current: -3.15

HKSE:02185's EV-to-FCF is ranked worse than
100% of 463 companies
in the Biotechnology industry
Industry Median: 2.31 vs HKSE:02185: -3.15

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-09), Shanghai Bio-heart Biological Technology Co's stock price is HK$1.95. Shanghai Bio-heart Biological Technology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-0.523. Therefore, Shanghai Bio-heart Biological Technology Co's PE Ratio (TTM) for today is At Loss.


Shanghai Bio-heart Biological Technology Co EV-to-FCF Historical Data

The historical data trend for Shanghai Bio-heart Biological Technology Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Bio-heart Biological Technology Co EV-to-FCF Chart

Shanghai Bio-heart Biological Technology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
- - -38.66 -5.12 -6.25

Shanghai Bio-heart Biological Technology Co Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only - -5.12 - -6.25 -

Competitive Comparison of Shanghai Bio-heart Biological Technology Co's EV-to-FCF

For the Biotechnology subindustry, Shanghai Bio-heart Biological Technology Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Bio-heart Biological Technology Co's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Bio-heart Biological Technology Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Shanghai Bio-heart Biological Technology Co's EV-to-FCF falls into.


;
;

Shanghai Bio-heart Biological Technology Co EV-to-FCF Calculation

Shanghai Bio-heart Biological Technology Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=196.962/-124.28
=-1.58

Shanghai Bio-heart Biological Technology Co's current Enterprise Value is HK$196.96 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Shanghai Bio-heart Biological Technology Co's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-124.28 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shanghai Bio-heart Biological Technology Co  (HKSE:02185) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Shanghai Bio-heart Biological Technology Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.95/-0.523
=At Loss

Shanghai Bio-heart Biological Technology Co's share price for today is HK$1.95.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Shanghai Bio-heart Biological Technology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-0.523.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Shanghai Bio-heart Biological Technology Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Shanghai Bio-heart Biological Technology Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Bio-heart Biological Technology Co Business Description

Traded in Other Exchanges
N/A
Address
No.590 Ruiqing Road, Room 302, 3rd Floor, Building 4 & Building 6, East Zhangjiang Hi-Tech Park, Pudong New Area, Shanghai, CHN
Shanghai Bio-heart Biological Technology Co Ltd is engaged in the research and development of bioresorbable scaffold (BRS) products and the renal denervation (RDN) system. The company is a interventional cardiovascular device company in China, and locate in Shanghai Zhangjiang Hi-Tech Park Medical Device Industrial Park. Focused on two therapies, bioresorbable scaffolds (BRS) and renal denervation (RDN), addressing the unmet medical needs of Chinese patients for the treatment of coronary and peripheral artery diseases and uncontrolled hypertension.
Executives
Tpg Operating Group Ii, L.p. 2201 Interest of corporation controlled by you
Chen Hao 2201 Interest of corporation controlled by you
Zhu Linan 2201 Interest of corporation controlled by you
Wang Nengguang 2201 Interest of corporation controlled by you
Union Season Holdings Limited 2201 Interest of corporation controlled by you
Sk China Company Limited 2201 Interest of corporation controlled by you
Right Lane Limited 2201 Interest of corporation controlled by you
Proud Solar Limited 2201 Interest of corporation controlled by you
Magic Grace Limited 2101 Beneficial owner
Loft Success Investments Limited 2201 Interest of corporation controlled by you
Lc Healthcare Fund Ii, L.p. 2201 Interest of corporation controlled by you
Lc Healthcare Fund Ii Gp Limited 2201 Interest of corporation controlled by you
Lc Fund Gp Limited 2201 Interest of corporation controlled by you
Great Unity Fund I, L.p. 2201 Interest of corporation controlled by you
Lian Xiang Kong Gu Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you

Shanghai Bio-heart Biological Technology Co Headlines

No Headlines